Jasper Ridge Partners L.P. Invests $823,000 in Genpact Limited (NYSE:G)

Jasper Ridge Partners L.P. acquired a new position in Genpact Limited (NYSE:G - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 19,155 shares of the business services provider's stock, valued at approximately $823,000.

Several other hedge funds and other institutional investors have also modified their holdings of G. Coppell Advisory Solutions LLC boosted its stake in Genpact by 529.5% during the fourth quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock worth $25,000 after buying an additional 503 shares in the last quarter. SRH Advisors LLC bought a new position in shares of Genpact during the fourth quarter valued at $26,000. Atlas Capital Advisors Inc. lifted its holdings in shares of Genpact by 55.8% during the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock valued at $26,000 after acquiring an additional 216 shares during the period. GeoWealth Management LLC lifted its holdings in shares of Genpact by 199.0% during the fourth quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock valued at $38,000 after acquiring an additional 583 shares during the period. Finally, Manchester Capital Management LLC bought a new position in shares of Genpact during the fourth quarter valued at $38,000. Institutional investors and hedge funds own 96.03% of the company's stock.

Wall Street Analysts Forecast Growth

G has been the subject of a number of analyst reports. TD Cowen raised Genpact from a "hold" rating to a "buy" rating and lifted their price objective for the company from $45.00 to $60.00 in a report on Friday, February 7th. Needham & Company LLC cut their price objective on Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a report on Thursday, May 8th. Mizuho lifted their price objective on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Jefferies Financial Group raised Genpact from a "hold" rating to a "buy" rating and lifted their price target for the company from $44.00 to $55.00 in a report on Tuesday, January 21st. Finally, Robert W. Baird cut their price target on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a report on Thursday, May 8th. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $50.71.

Insiders Place Their Bets

In related news, Director Nicholas C. Gangestad bought 2,000 shares of the firm's stock in a transaction dated Tuesday, May 13th. The stock was bought at an average cost of $43.97 per share, for a total transaction of $87,940.00. Following the transaction, the director now owns 2,000 shares of the company's stock, valued at $87,940. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now owns 310,246 shares of the company's stock, valued at $15,167,926.94. The trade was a 4.20% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 3.07% of the company's stock.

Genpact Price Performance

Shares of Genpact stock traded down $0.46 during trading on Wednesday, reaching $43.26. The company's stock had a trading volume of 1,639,746 shares, compared to its average volume of 1,361,321. The stock has a 50-day moving average price of $48.25 and a two-hundred day moving average price of $47.05. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. Genpact Limited has a one year low of $30.38 and a one year high of $56.76. The stock has a market capitalization of $7.60 billion, a P/E ratio of 15.23, a price-to-earnings-growth ratio of 1.84 and a beta of 1.02.

Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.04. The firm had revenue of $1.21 billion during the quarter, compared to analysts' expectations of $1.21 billion. Genpact had a return on equity of 22.50% and a net margin of 10.77%. The company's quarterly revenue was up 7.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.73 EPS. As a group, sell-side analysts anticipate that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.